Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 123, 2017 - Issue 5
112
Views
11
CrossRef citations to date
0
Altmetric
Original Article

A synergistic protective effect of selenium and taurine against experimentally induced myocardial infarction in rats

Pages 344-355 | Received 21 Mar 2017, Accepted 22 Jun 2017, Published online: 12 Jul 2017

References

  • Abdel-Rahman, G.H., 2014. Taurine attenuates hepatic and cardiac damage and apoptosis in rabbits fed a high-fat diet. OnLine Journal of Biological Sciences, 14 (1), 12–20.
  • Ardisson, L.P., et al., 2013. Taurine attenuates cardiac remodeling after myocardial infarction. International Journal of Cardiology, 168 (5), 4925–4936.
  • Anversa, P., et al., 1998. Apoptosis and myocardial infarction. Basic Research in Cardiology, 93(Suppl.3): 8–12.
  • Bordoni, A., et al., 2005. Susceptibility to hypoxia/reoxygenation of aged rat cardiomyocytes and its modulation by selenium supplementation. Journal of Agricultural and Food Chemistry, 53, 490–494.
  • Center for Drug Evaluation and Research (CDER), U.S. Department of Health and Human Services Food and Drug Administration. 2013. Guidance for Industry Codevelopment of Two or More New Investigational Drugs for Use in Combination. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM236669.pdf
  • Chen, M., et al., 1995. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide. Cancer Research, 55, 991–994.
  • Chen, X., et al., 1980. Studies on the relations of selenium and Keshan disease. Biological Trace Element Research, 2, 91–107.
  • Chapman, R.A., Suleiman, M.S., and Earn, Y.E., 1993. Taurine and the heart. Cardiovascular Research, 27, 358–363.
  • Dietary Reference Intakes (DRI) 2000. In National Research Council. Washington, DC, USA: National Academy Press, pp. 284–319.
  • Dubois-Rande, J.L., et al., 1994. Oxidative 17 stress in patients with unstable angina. European Heart Journal, 15, 179–183.
  • Ebermann, L., et al., 2009. Impact of myocardial inflammation on cytosolic and mitochondrial creatine kinase activity and expression. Basic Research in Cardiology, 104, 247–257.
  • Eleawa, S.M., et al., 2015. Coenzyme Q10 protects against acute consequences of experimental myocardial infarction in rats. International Journal of Physiology, Pathophysiology and Pharmacology, 7 (1), 1–13.
  • Elsasser, A., Suzuki, K., and Schaper, J., 2000. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. Journal of Molecular and Cellular Cardiology, 32 (5), 711–724.
  • Franke, K.W., and Moxon, A.L., 1936. A comparison of the minimum fatal doses of selenium, tellurium, arsenic, and vanadium. Journal of Pharmacology and Experimental Therapeutics, 58, 454–459.
  • Friess, U., and Stark, M., 2009. Cardiac markers: a clear cause for point-of-care testing. Analytical and Bioanalytical Chemistry, 393, 1453–1462.
  • Galler, S., Hutzler, C., and Haller, T., 1990. Effects of taurine on Ca2(+)-dependent force development of skinned muscle fibre preparations. The Journal of Experimental Biology, 152, 255–264.
  • Greco, D.S., Biller, B., and Van-Liew, C.H., 2003. Measurement of plasma atrial natriuretic peptide as an indicator of prognosis in dogs with cardiac disease. The Canadian Veterinary Journal = La Revue Veterinaire Canadienne, 44 (4), 293–297.
  • Gupta, R.C., Win, T., and Bittner, S., 2005. Taurine analogues; a new class of therapeutics: retrospect and prospects. Current Medicinal Chemistry, 12, 2021–2039.
  • Gupta, R., 2008. Recent trends in Coronary heart disease epidemiology in India. Indian Heart Journal, 60, 34–18.
  • Hafeman, D.G., Sunde, R.A., and Hoekstra, W.G., 1974. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. The Journal of Nutrition, 104, 580–586.
  • Harr, J. R., et al., 1967. Selenium toxicity in Rats II. Histopathology. [In: Muth, O. H. eds. Selenium in biomedicine Westport.] CT: AVI Publishing Co. Inc. 153–178.
  • Ibrahim, S.S., Barakat, M.A., and Helmy, H.M., 2010. Role of Selenium in Attenuating Cardiac and Hepatic Damages Induced By the Antitumor Agent, Doxorubicin. Life Science Journal, 7 (4), 162–174.
  • Ikeda, U., et al., 1992. Serum interleukin 6 levels become elevated in acute myocardial infarction. Journal of Molecular and Cellular Cardiology, 24, 579–584.
  • Jong, C.J., Azuma, J., and Schaffer, S., 2012. Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids, 42, 2223–2232.
  • Jong, C.J., et al., 2010. Effect of beta-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content. Journal of Biomedical Science, 17, S25.
  • Kajstura, J., et al., 1996. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Laboratory Investigation; a Journal of Technical Methods and Pathology, 74 (1), 86–107.
  • Kapadia, S.R., et al., 1997. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circulation Research, 81, 187–195.
  • Kramer, J.H., Chovan, J.P., and Schaffer, S.W., 1981. Effect of taurine on calcium paradox and ischemic heart failure. The American Journal of Physiology, 240, H238–H246.
  • Krown, K.A., et al., 1995. TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-type Ca2+ current and Ca2+ transients. FEBS Letters, 376, 24–30.
  • Levy, D., Kannel, W.B., and Vasan, R.S., 2008. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation, 118, 2057–2062.
  • Lijnen, P.J., Petrov, V.V., and Fagard, R.H., 2000. Induction of cardiac fibrosis by transforming growth factor-beta(1). Molecular Genetics and Metabolism, 71, 418–435.
  • Meldrum, D. R., et al., 1998. Hydrogen peroxide induces tumor necrosis factor alphamediated cardiac injury by a p38 mitogen activated protein kinasedependent mechanisms.
  • McMurray, J., et al., 1990. Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol, 1990, 65, 1261–1262.
  • McCarty, M.F., 2004. A taurine-supplemented vegan diet may blunt the contribution of neutrophil activation to acute coronary events. Medical Hypotheses, 63, 419–425.
  • Mohanty, I., Gupta, S.K., and Arya, D.S., 2007. Anti-apoptotic and cardioprotective effects of an herbal combination in rats with experimental myocardial infarction. International Journal of Integrative Biology, 1, 178–188.
  • Mueller, A.S., and Pallauf, J., 2006. Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice. The Journal of Nutritional Biochemistry, 17, 548–560.
  • Nakamura, K., et al., 1998. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation, 98, 794–799.
  • Ostadalova, I., et al., 2007. Selenium protects the immature rat heart against ischemia/reperfusion injury. Molecular and Cellular Biochemistry, 300, 259–267.
  • Oriyanhan, W., et al., 2005. Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart and Vessels, 20, 278–285.
  • Oster, O., et al., 1983. Congestive cardiomyopathy and the selenium content of serum. Clinica Chimica Acta; International Journal of Clinical Chemistry, 128, 125–132.
  • Poltronieri, R., Cevese, A., and Sbarbati, A., 1992. Protective effect of selenium in cardiac ischemia and reperfusion. Cardioscience, 3, 155–160. 15.
  • Pucheu, S., et al., 1995. Effect of dietary antioxidant trace element supply on cardiac tolerance to ischemia-reperfusion in the rat. Journal of Molecular and Cellular Cardiology, 27, 2303–2314.
  • Rosamond, W., and Flegal, K., 2008. American Heart Association Statistics Committee. Circulation, 117, 25–146.
  • Salonen, J.T., et al., 1982. Association, between cardiovascular death and myocardial infarction and serum selenium in a matched pair longitudinal study. Lancet, 2, 175–191.
  • Schaffer, S.W., Azuma, J., and Mozaffari, M., 2009. Role of antioxidant activity of taurine in diabetes. Canadian Journal of Physiology and Pharmacology, 87, 91–99.
  • Schaffer, S.W., et al., 2010. Physiological roles of taurine in heart and muscle. Journal of Biomedical Science, 17(Suppl1), S2.
  • Schaffer, S.W., et al., 2002. Effect of ischemia, calcium depletion and repletion, acidosis and hypoxia on cellular taurine content. Amino Acids, 23, 395–400.
  • Schaffer, S.W., et al., 1992. Mechanism underlying physiological modulation of myocardial contraction by taurine. Advances in Experimental Medicine and Biology, 1992315, 193–198.
  • Schulz, R., et al., 2004. TNFα in ischemia/reperfusion injury and heart failure. Basic Research in Cardiology, 99 (1), 8–11.
  • Singh, R.B., et al., 2003. Effect of taurine and coenzyme Q10 in patients with acute myocardial infarction. Advances in Experimental Medicine and Biology, 526, 41–48.
  • Smith, M.I., Stohlman, E.F., and LILLIE, R.D., 1937. The toxicity and pathology of selenium. Journal of Pharmacology and Experimental Therapeutics, 60, 449–471.
  • Stadtman, T.C., 1991. Biosynthesis and function of selenocysteine-containing enzymes. The Journal of Biological Chemistry, 266 (25), 16257–16260.
  • Turan, B., et al., 2005. Selenium improves cardiac function by attenuating the activation of NF-kappaB due to ischemiareperfusion injury. Antioxid Redox Signal, 7, 1388–1397.
  • Thurston, J.H., Hauhart, R.E., and Naccarato, E.F., 1981. Taurine: possible role in osmotic regulation of mammalian heart. Science (New York, N.Y.), 214, 1373–1374.
  • Thygesen, K., Alpert, J.S., and White, H.D., 2007. Universal Definition of Myocardial Infarction. Circulation, 116, 2634–2653.
  • Tinsley, I. J., Harr, J. R., Bone, J. F., Weswig, P. H., Yamamoto, R. S., et al., 1967. Selenium toxicity in rats I. Growth and longevity. [In:Muth, O. H. eds. Selenium in biomedicine.] Westport. CT: AVI Publishing Co. Inc. 141–152.
  • Ueno, T., et al., 2007. Taurine at early reperfusion significantly reduces myocardial damage and preserves cardiac function in the isolated rat heart. Resuscitation, 73, 287–295.
  • Venardos, K., et al., 2005. Effects of dietary selenium on post-ischemic expression of antioxidant mRNA. Molecular and Cellular Biochemistry, 270, 131–138.
  • Venardos, K., et al., 2004. Selenium supplementation and ischemia-reperfusion injury in rats. Redox Report, 9, 317–320. 16.
  • Xu, Y.J., et al., 2006. MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine. Cardiovascular Research, 72, 163–174.
  • Yamauchi-Takihara, K., et al., 2004. Taurine prevention of calcium paradox-related damage in cardiac muscle. Its regulatory action on intracellular Kingston R, Kelly CJ, Murray P. The therapeutic role of taurine in ischaemia-reperfusion injury. Current Pharmaceutical Design, 10, 2401–2410.
  • Zhao, Z.Q., 2004. Oxidative stress-elicited myocardial apoptosis during reperfusion. Current Opinion in Pharmacology, 4, 159–165.
  • Zimmet, J.M., and Hare, J.M., 2006. Nitroso-redox interactions in the cardiovascular system. Circulation, 114, 1531– 1544.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.